Ozette
“High-Resolution Immune Profiling”
Ozette’s immune profiling platform uses cutting edge A.I. to analyze proteins 100x faster and provide insights that answer pressing questions for scientists—such as why a therapy works for one patient but not another. The goal is to significantly increase the overall throughput of drugs and therapies for pharma companies and improve the overall clinical trial success rate (currently FDA only approves 14%).
Founders

Ali Ansary, PhD

Greg Finak, PhD
